Recombinant Human Papillomavirus (HPV) Nonavalent Vaccine

Recombinant Human Papillomavirus (HPV) Nonavalent Vaccine · Recombinant Prophylactic HPV Cancer Vaccine

Back to Cancer Drug Encyclopedia Find Recruiting Trials with this Drug →

Indications & Uses

Prevention of HPV-associated cervical, vulvar, vaginal, anal, and oropharyngeal cancers.

Contraindications

Hypersensitivity to active ingredient or any formulation excipients.

Side Effects & Warnings

Injection site pain, erythema, swelling, syncope, headache, low-grade pyrexia.

Drug & Dietary Interactions

Caution with strong CYP3A inhibitors or inducers; review concurrent medications.

For educational and informational purposes only. Do not alter medication doses or regimens without consulting your licensed oncology physician or care team.

Patient & Caregiver Support

Ask About This Medication

Connect with an ONC-ORG counselor regarding drug access, copay relief, patient assistance programs, or related clinical trials.